immune system
• when mice are injected successively with MHC class I-mismatched splenocytes and CFSE-labeled naive CD8+ T cells expressing a specific TCR, proliferation of cross-primed CD8+ T cells is reduced by two-thirds compared to similarly treated wild-type cells
|
• cytotoxic response to immunodominant NP396-404 is decreased compared to in wild-type cells
• however, cytotoxic response to LCMV (lymphocytic choriomeningitis virus) infection is normal
|
• mice exhibit reduced efficiency of cross-presentation of cell-associated antigens and of ovalbumin/anti-ovalbumin immunocomplexes
• however, cross-presentation of soluble ovalbumin is normal
|
• expression of MHC class I proteins at the cell surface is reduced in splenocytes, dendritic cells from bone marrow precursors, and immature bone marrow-derived dendritic cells treated with IFN-gamma compared to similarly treated wild-type cells
• however, expression of MHC class II proteins at the cell surface is normal
|
• NP396-404 specific cytotoxic T lymphocytes stimulated by LCMV-infected dendritic cells derived from bone marrow precursors produce less IFN-gamma than similarly treated wild-type cells
• however, prepulsed dendritic cells stimulate cytotoxic T lymphocytes normally
|
• mice primed with the NP396-404 peptide and challenged with LCMV exhibit reduced clearance efficiency compared to similarly treated wild-type mice
• however, response to LCMV (lymphocytic choriomeningitis virus) infection is otherwise normal
|
hematopoietic system
• when mice are injected successively with MHC class I-mismatched splenocytes and CFSE-labeled naive CD8+ T cells expressing a specific TCR, proliferation of cross-primed CD8+ T cells is reduced by two-thirds compared to similarly treated wild-type cells
|
• cytotoxic response to immunodominant NP396-404 is decreased compared to in wild-type cells
• however, cytotoxic response to LCMV (lymphocytic choriomeningitis virus) infection is normal
|
cellular
• when mice are injected successively with MHC class I-mismatched splenocytes and CFSE-labeled naive CD8+ T cells expressing a specific TCR, proliferation of cross-primed CD8+ T cells is reduced by two-thirds compared to similarly treated wild-type cells
|